Bli medlem
Bli medlem

Du är här

2016-11-02

Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016

Novavax, Inc.
Press release

Novavax to Host Conference Call to Discuss Third Quarter Financial Results on
November 9, 2016

Financial results conference call will include Investor and Analyst webcast
presentation

GAITHERSBURG, Md., 2016-11-02 21:05 CET (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX) today announced it will host an Investor and
Analyst update as part of its third quarter financial results conference call
and webcast after the close of U.S. financial markets on Wednesday, November 9,
2016.

Management will host a conference call to discuss the quarterly financial
results and provide an update on corporate activities. Please be sure to join
the webcast in order to access the slide presentation.

Conference call details are as follows:

Date: Wednesday, November 9, 2016
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode: 10126707
Webcast: www.novavax.com, “Investors”/ “Events”

Conference call replay:

Dates: Starting at 7:30 p.m. ET, August 9, 2016 until August 16,
2016
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode: 10126707
Webcast: www.novavax.com, “Investors”/ “Events”

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation
for groundbreaking innovation that improves global health through safe and
effective vaccines.

Contact:

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

ir@novavax.com
240-268-2000

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.